You are on page 1of 8

Renub Research

Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA)
Forecast

www.renub.com

Global Cervical Cancer Screening Market &


Patients, By Test Type (Pap Smear, HPV DNA, VIA)
Forecast

Renub Research Page 1 of 8

Published: February, 2017


Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA)
Forecast

Global Cervical Cancer Screening Market Forecast

Table of Contents
1. Executive Summary

2. Global Cervical Cancer Test (Screening) Population & Forecast

2.1 Asia Cervical Cancer Test (Screening) Population & Forecast

2.2 Europe Cervical Cancer Test (Screening) Population & Forecast

2.3 North America Cervical Cancer Test (Screening) Population & Forecast

3. Global Cervical Cancer Test (Screening) Market & Forecast

3.1 Global Cervical Cancer Pap Smear Test (Screening) Market & Forecast

3.2 Global Cervical Cancer HPV DNA Test (Screening) Market & Forecast

3.3 Global - Cervical Cancer Visual Inspection with Acetic Acid (VIA) Test (Screening) Market &
Forecast

4. By Region Global Cervical Cancer Test (Screening) Market Analysis

4.1 Asia Cervical Cancer Test (Screening) Market & Forecast

4.2 Europe Cervical Cancer Test (Screening) Market & Forecast

4.3 North America Cervical Cancer Test (Screening) Market & Forecast

5. Global Cervical Cancer Test (Screening) Population Share & Forecast

5.1 By Region Global Cervical Cancer Test (Screening) Population Share & Forecast

5.2 By Countries Global Cervical Cancer Test (Screening) Population Country Share & Forecast

6. Global Cervical Cancer Test (Screening) Market Share & Forecast

6.1 By Region Global Cervical Cancer Test (Screening) Market Share & Forecast

6.2 By Countries Global Cervical Cancer Test (Screening) Market Share & Forecast

6.3 By Countries Global Pap Smear Test (Screening) Market Share & Forecast

6.4 By Countries Global HPV DNA Test (Screening) Market Share & Forecast

6.5 By Countries Global VIA Test (Screening) Market Share & Forecast

7. United Kingdom Cervical Cancer Test Analysis

7.1 United Kingdom Cervical Cancer Test (Screening) Population


7.1.1 United Kingdom Cervical Cancer Pap Smear Test Population & Forecast

Renub Research Page 2 of 8


Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA)
Forecast
7.1.2 United Kingdom Cervical Cancer HPV DNA Test Population & Forecast

7.2 United Kingdom Cervical Cancer Deaths

7.3 United Kingdom Cervical Cancer Test (Screening) Analysis


7.3.1 United Kingdom Cervical Cancer Test Market & Forecast
7.3.2 United Kingdom Pap Smear Test Market & Forecast
7.3.3 United Kingdom HPV DNA Test Market & Forecast

8. France Cervical Cancer Test Analysis

8.1 France Cervical Cancer Test (Screening) Population


8.1.1 France Cervical Cancer Pap Smear Test Population & Forecast
8.1.2 France Cervical Cancer HPV DNA Test Population & Forecast

8.2 France Cervical Cancer Mortality

8.3 France Cervical Cancer Test (Screening) Analysis


8.3.1 France Cervical Cancer Test Market & Forecast
8.3.2 France Pap Smear Test Market & Forecast
8.3.3 France HPV DNA Test Market & Forecast

9. Germany Cervical Cancer Test Analysis

9.1 Germany Cervical Cancer Test (Screening) Population


9.1.1 Germany Cervical Cancer Pap Smear Test Population & Forecast
9.1.2 Germany Cervical Cancer HPV DNA Test Population & Forecast

9.2 Germany Cervical Cancer Mortality

9.3 Germany Cervical Cancer Test (Screening) Market


9.3.1 Germany Cervical Cancer Test Market & Forecast
9.3.2 Germany Pap Smear Test Market & Forecast
9.3.3 Germany HPV DNA Test Market & Forecast

10. Italy Cervical Cancer Test Analysis

10.1 Italy Cervical Cancer Test (Screening) Population


10.1.1 Italy Cervical Cancer Pap Smear Test Population & Forecast
10.1.2 Italy Cervical Cancer HPV DNA Test Population & Forecast

10.2 Italy Cervical Cancer Mortality

10.3 Italy Cervical Cancer Test (Screening) Market


10.3.1 Italy Cervical Cancer Test Market & Forecast
10.3.2 Italy Pap Smear Test Market & Forecast
10.3.3 Italy HPV DNA Test Market & Forecast

Renub Research Page 3 of 8


Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA)
Forecast
11. Spain Cervical Cancer Test Analysis

11.1 Spain Cervical Cancer Test (Screening) Population


11.1.1 Spain Cervical Cancer Pap Smear Test Population & Forecast
11.1.2 Spain Cervical Cancer HPV DNA Test Population & Forecast

11.2 Spain Cervical Cancer Mortality

11.3 Spain Cervical Cancer Test (Screening) Market


11.3.1 Spain Cervical Cancer Test Market & Forecast
11.3.2 Spain Pap Smear Test Market & Forecast
11.3.3 Spain HPV DNA Test Market & Forecast

12. Sweden Cervical Cancer Test Analysis

12.1 Sweden Cervical Cancer Test (Screening) Population


12.1.1 Sweden Cervical Cancer Pap Smear Test Population & Forecast
12.1.2 Sweden Cervical Cancer HPV DNA Test Population & Forecast

12.2 Sweden Cervical Cancer Mortality

12.3 Sweden Cervical Cancer Test (Screening) Market


12.3.1 Sweden Cervical Cancer Test Market & Forecast
12.3.2 Sweden Pap Smear Test Market & Forecast
12.3.3 Sweden HPV DNA Test Market & Forecast

13. Switzerland Cervical Cancer Test Analysis

13.1 Switzerland Cervical Cancer Test (Screening) Population


13.1.1 Switzerland Cervical Cancer Pap Smear Test Population & Forecast
13.1.2 Switzerland Cervical Cancer HPV DNA Test Population & Forecast

13.2 Switzerland Cervical Cancer Mortality

13.3 Switzerland Cervical Cancer Test (Screening) Market


13.3.1 Switzerland Cervical Cancer Test Market & Forecast
13.3.2 Switzerland Pap Smear Test Market & Forecast
13.3.3 Switzerland HPV DNA Test Market & Forecast

14. Norway Cervical Cancer Test Analysis

14.1 Norway Cervical Cancer Test (Screening) Population


14.1.1 Norway Cervical Cancer Pap Smear Test Population & Forecast
14.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast

14.2 Norway Cervical Cancer Mortality

Renub Research Page 4 of 8


Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA)
Forecast
14.3 Norway Cervical Cancer Test (Screening) Market
14.3.1 Norway Cervical Cancer Test Market & Forecast
14.3.2 Norway Pap Smear Test Market & Forecast
14.3.3 Norway HPV DNA Test Market & Forecast

15. Netherlands Cervical Cancer Test Analysis

15.1 Netherlands Cervical Cancer Test (Screening) Population


15.1.1 Netherlands Cervical Cancer Pap Smear Test Population & Forecast
15.1.2 Netherlands Cervical Cancer HPV DNA Test Population & Forecast

15.2 Netherlands Cervical Cancer Mortality

15.3 Netherlands Cervical Cancer Test (Screening) Market


15.3.1 Netherlands Cervical Cancer Test Market & Forecast
15.3.2 Netherlands Pap Smear Test Market & Forecast
15.3.3 Netherlands HPV DNA Test Market & Forecast

16. United States Cervical Cancer Test Analysis

16.1 United States Cervical Cancer Test (Screening) Population


16.1.1 United States Cervical Cancer Pap Smear Test Population & Forecast
16.1.2 United States Cervical Cancer HPV DNA Test Population & Forecast

16.2 United States Cervical Cancer Mortality

16.3 United States Cervical Cancer Test (Screening) Market


16.3.1 United States Cervical Cancer Test Market & Forecast
16.3.2 United States Pap Smear Test Market & Forecast
16.3.3 United States HPV DNA Test Market & Forecast

17. Canada Cervical Cancer Test Analysis

17.1 Canada Cervical Cancer Test (Screening) Population


17.1.1 Canada Cervical Cancer Pap Smear Test Population & Forecast
17.1.2 Canada Cervical Cancer HPV DNA Test Population & Forecast

17.2 Canada Cervical Cancer Mortality

17.3 Canada Cervical Cancer Test (Screening) Market


17.3.1 Canada Cervical Cancer Test Market & Forecast
17.3.2 Canada Pap Smear Test Market & Forecast
17.3.3 Canada HPV DNA Test Market & Forecast

18. Japan Cervical Cancer Test Analysis

18.1 Japan Cervical Cancer Test (Screening) Population

Renub Research Page 5 of 8


Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA)
Forecast
18.1.1 Japan Cervical Cancer Pap Smear Test Population & Forecast
18.1.2 Japan Cervical Cancer HPV DNA Test Population & Forecast

18.2 Japan Cervical Cancer Mortality

18.3 Japan Cervical Cancer Test (Screening) Market


18.3.1 Japan Cervical Cancer Test Market & Forecast
18.3.2 Japan Pap Smear Test Market & Forecast
18.3.3 Japan HPV DNA Test Market & Forecast

19. South Korea Cervical Cancer Tests Analysis

19.1 South Korea - Cervical Cancer Test (Screening) Population


19.1.1 South Korea - Cervical Cancer Pap Smear Test Population & Forecast
19.1.2 Korea Cervical Cancer HPV DNA Test Population & Forecast

19.2 Korea Cervical Cancer Mortality

19.3 Korea Cervical Cancer Test (Screening) Market


19.3.1 Korea Cervical Cancer Test Market & Forecast
19.3.2 Korea Pap Smear Test Market & Forecast
19.3.3 Korea HPV DNA Test Market & Forecast

20. Singapore Cervical Cancer Tests Analysis

20.1 Singapore - Cervical Cancer Test (Screening) Population


20.1.1 Singapore - Cervical Cancer Pap Smear Test Population & Forecast
20.1.2 Singapore Cervical Cancer HPV DNA Test Population & Forecast

20.2 Singapore Cervical Cancer Test (Screening) Market


20.2.1 Singapore Cervical Cancer Test Market & Forecast
20.2.2 Singapore Pap Smear Test Market & Forecast
20.2.3 Singapore HPV DNA Test Market & Forecast

21. Malaysia Cervical Cancer Test Analysis

21.1 Malaysia - Cervical Cancer Test (Screening) Population


21.1.1 Malaysia Cervical Cancer Pap Smear Test Population & Forecast
21.1.2 Malaysia Cervical Cancer HPV DNA Test Population & Forecast

21.2 Malaysia Cervical Cancer Test (Screening) Market


21.2.1 Malaysia Cervical Cancer Test Market & Forecast
21.2.2 Malaysia Pap Smear Test Market & Forecast
21.2.3 Malaysia HPV DNA Test Market & Forecast

22. India Cervical Cancer Test Analysis

Renub Research Page 6 of 8


Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA)
Forecast
22.1 India - Cervical Cancer Test (Screening) Population
22.1.1 India Cervical Cancer Pap Smear Test Population & Forecast
22.1.2 India Cervical Cancer HPV DNA Test Population & Forecast
22.1.3 India Cervical Cancer VIA Test Population & Forecast

22.2 India Cervical Cancer Test (Screening) Market


22.2.1 India Cervical Cancer Test Market & Forecast
22.2.2 India Pap Smear Test Market & Forecast
22.2.3 India HPV DNA Test Market & Forecast
22.2.4 India VIA Test Market & Forecast

23. China Cervical Cancer Test Analysis

23.1 China - Cervical Cancer Test (Screening) Population


23.1.1 China Cervical Cancer Pap smear Test Population & Forecast
23.1.2 China Cervical Cancer HPV DNA Test Population & Forecast
23.1.3 China Cervical Cancer VIA Test Population & Forecast

23.2 China - Cervical Cancer Test (Screening) Market


23.2.1 China Cervical Cancer Test Market & Forecast
23.2.2 China Pap Smear Test Market & Forecast
23.2.3 China HPV DNA Test Market & Forecast
23.2.4 China VIA Test Market & Forecast

24. Thailand Cervical Cancer Test Analysis

24.1 Thailand - Cervical Cancer Test (Screening) Population


24.1.1 Thailand Cervical Cancer Pap Smear Test Population & Forecast
24.1.2 Thailand Cervical Cancer VIA Test Population & Forecast

24.2 Thailand Cervical Cancer Test (Screening) Market


24.2.1 Thailand Cervical Cancer Test Market & Forecast
24.2.2 Thailand Pap smear Test Market & Forecast
24.2.3 Thailand VIA Test Market & Forecast

25. Indonesia Cervical Cancer Test Analysis

25.1 Indonesia Cervical Cancer Test (Screening) Population


25.1.1 Indonesia Cervical Cancer Pap Smear Test Population & Forecast
25.1.2 Indonesia Cervical Cancer HPV DNA Test Population & Forecast
25.1.3 Indonesia Cervical Cancer VIA Test Population & Forecast
25.1.4 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Population & Forecast

25.2 Indonesia Cervical Cancer Test (Screening) Market

Renub Research Page 7 of 8


Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA)
Forecast
25.2.1 Indonesia Cervical Cancer Test Market & Forecast
25.2.2 Indonesia Pap smear Test Market & Forecast
25.2.3 Indonesia HPV DNA Test Market & Forecast
25.2.4 Indonesia VIA Test Market & Forecast
25.2.5 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Market & Forecast

26. Cervical Cancer Test Market Growth Drivers

26.1 Introduction of Low Cost VIA Test


26.1.1 Countries Offering VIA Test via National Programs
26.1.2 Countries Offering VIA Test via Pilot Programs

26.2 Worldwide High Prevalence of HPV Infected Patients

26.3 Rising Number of Incidence of Cervical Cancer in United Kingdom

26.4 Worldwide Rising Incidence of Teenage Sexual Cases

27. Challenges in Cervical Cancer Test Market

27.1 Lack of Appropriate Healthcare Infrastructure

27.2 Introduction of HPV Vaccination Programs Worldwide

Download full Report:

http://www.renub.com/global-cervical-cancer-screening-market-and-patients-by-test-type-pap-
smear-hpv-dna-via-forecast-1009-p.php

Medical Devices Report:

http://www.renub.com/medical-devices-15-c.php

Renub Research - North America Renub Research - Asia


Rajat Gupta Ankit Mishra
225 Kristie Ln, Roswell C 86, Sector 10
Georgia 30076, United States Noida 201301, India
Tel: +1-678-302-0700 Tel: +91-120-421-9822 / 424-9780
Email: info@renub.com Email: info@renub.com
www.renub.com www.renub.com

Renub Research Page 8 of 8